Today’s clinic-facing learning begins with developmental dysplasia of the hip and alopecia. A reassuring newborn hip examination does not remove the need for imaging when recognised risk factors are present. First-degree family history and defined breech presentation should be documented deliberately, while a true palpable clunk is more concerning than an isolated soft-tissue click. Ultrasound is the initial investigation in younger infants, and a Pavlik harness is commonly used before six months to hold the hips flexed and abducted while acetabular development continues. Later features such as reduced abduction, unequal leg length, limp or delayed walking require specialist assessment.

Hair loss assessment starts with a similarly decisive clinical distinction: are the follicles preserved? Non-scarring conditions such as androgenetic alopecia, alopecia areata and telogen effluvium retain the potential for regrowth. Reduced follicular openings, perifollicular redness or scale, scalp discomfort and progressive eyebrow or frontal hairline loss suggest a scarring process in which treatment aims to protect the remaining follicles. Diffuse shedding should prompt a review of illness, surgery, childbirth, stress, nutrition and medication changes two to three months before symptoms began. Suspected scarring alopecia warrants prompt dermatology assessment and possible biopsy rather than prolonged reassurance.

The surgical episode examines when a bioresorbable mesh may offer an advantage during ventral hernia repair. These implants provide temporary support while avoiding a permanent prosthetic, but degradation speed varies and rapidly absorbable materials may lose strength before durable healing occurs. The operation itself remains central: fascial closure, a retromuscular or sublay plane, generous overlap and sound abdominal-wall mechanics appear more important than the material label alone. Bioresorbable mesh may be useful in selected contaminated or staged repairs, but recurrence, infection, cost and patient preferences still need explicit discussion.

Neurology appears through both diagnostic overlap and trauma-informed care. Susac syndrome should not be excluded because encephalopathy, branch retinal artery occlusion and sensorineural hearing loss have not appeared together. MRI brain, fluorescein angiography and audiometry can identify partial disease. A Behçet label should also be revisited when onset is unusually early, family history is present or the phenotype behaves atypically; active mucosal lesions may need viral testing, and some presentations reflect monogenic immune dysregulation rather than classical vasculitis.

The migraine episode shows how clinical context can alter care without creating a new headache subtype. Military sexual trauma is associated with greater migraine burden and emergency healthcare use among veterans. Sensitive, permission-based enquiry can identify trauma-associated distress, complex pain and opioid exposure that will not be addressed by acute migraine medication alone. The prostate cancer discussion similarly broadens treatment beyond disease markers: fatigue, weight gain, reduced strength and sarcopenia should prompt realistic movement and resistance plans, with peer support or prehabilitation used where available.